Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PRAX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 837 | $315.71 | $264.2K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 1,279 | $314.90 | $402.8K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 504 | $313.66 | $158.1K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 1,004 | $312.83 | $314.1K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 2,854 | $311.91 | $890.2K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 1,750 | $310.89 | $544.1K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 999 | $309.38 | $309.1K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 1,240 | $308.24 | $382.2K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 683 | $306.77 | $209.5K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 320 | $305.31 | $97.7K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 120 | $303.13 | $36.4K Sale | Form 4 ↗ |
| Jun 24, 2026 | Jill DeSimone Director | PRAX Praxis Precision Medicines, Inc. | Sale | 10 | $301.44 | $3,014 Sale | Form 4 ↗ |
| Nov 20, 2025 | Alex Nemiroff General Counsel and Secretary | PRAX Praxis Precision Medicines, Inc. | Sale | 9,100 | $194.30 | $1.8M Sale | Form 4 ↗ |
| Nov 20, 2025 | Alex Nemiroff General Counsel and Secretary | PRAX Praxis Precision Medicines, Inc. | Sale | 977 | $193.23 | $188.8K Sale | Form 4 ↗ |
| Nov 20, 2025 | Alex Nemiroff General Counsel and Secretary | PRAX Praxis Precision Medicines, Inc. | Sale | 13,339 | $192.53 | $2.6M Sale | Form 4 ↗ |
| Nov 20, 2025 | Alex Nemiroff General Counsel and Secretary | PRAX Praxis Precision Medicines, Inc. | Sale | 1,714 | $190.86 | $327.1K Sale | Form 4 ↗ |
| Nov 20, 2025 | Lauren Mastrocola Principal Accounting Officer | PRAX Praxis Precision Medicines, Inc. | Sale | 2,145 | $192.71 | $413.4K Sale | Form 4 ↗ |
| Nov 20, 2025 | Lauren Mastrocola Principal Accounting Officer | PRAX Praxis Precision Medicines, Inc. | Sale | 11,455 | $191.96 | $2.2M Sale | Form 4 ↗ |
| Oct 16, 2025 | Phillip Gross 10% owner | PRAX Praxis Precision Medicines, Inc. | Sale | 19,198 | $140.00 | $2.7M Sale | Form 4 ↗ |
| Oct 16, 2025 | Phillip Gross 10% owner | PRAX Praxis Precision Medicines, Inc. | Sale | 308 | $132.19 | $40.7K Sale | Form 4 ↗ |
| Oct 16, 2025 | Phillip Gross 10% owner | PRAX Praxis Precision Medicines, Inc. | Sale | 487 | $131.64 | $64.1K Sale | Form 4 ↗ |
| Oct 16, 2025 | Phillip Gross 10% owner | PRAX Praxis Precision Medicines, Inc. | Sale | 1,661 | $130.10 | $216.1K Sale | Form 4 ↗ |
| Oct 16, 2025 | Phillip Gross 10% owner | PRAX Praxis Precision Medicines, Inc. | Sale | 250,000 | $104.31 | $26.1M Sale | Form 4 ↗ |
| Oct 16, 2025 | Phillip Gross 10% owner | PRAX Praxis Precision Medicines, Inc. | Sale | 27,287 | $101.00 | $2.8M Sale | Form 4 ↗ |
| Oct 16, 2025 | Phillip Gross 10% owner | PRAX Praxis Precision Medicines, Inc. | Sale | 559 | $100.11 | $56.0K Sale | Form 4 ↗ |
| Oct 16, 2025 | Phillip Gross 10% owner | PRAX Praxis Precision Medicines, Inc. | Sale | 1,363 | $92.03 | $125.4K Sale | Form 4 ↗ |
| Oct 16, 2025 | Phillip Gross 10% owner | PRAX Praxis Precision Medicines, Inc. | Sale | 447 | $91.04 | $40.7K Sale | Form 4 ↗ |
| Oct 16, 2025 | Phillip Gross 10% owner | PRAX Praxis Precision Medicines, Inc. | Sale | 12,600 | $90.00 | $1.1M Sale | Form 4 ↗ |
| Nov 14, 2024 | Alex Nemiroff General Counsel and Secretary | PRAX Praxis Precision Medicines, Inc. | Sale | 8,239 | $80.20 | $660.8K Sale | Form 4 ↗ |
| Nov 14, 2024 | Lauren Mastrocola Principal Accounting Officer | PRAX Praxis Precision Medicines, Inc. | Sale | 5,188 | $81.78 | $424.3K Sale | Form 4 ↗ |
30 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:11 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances